Trials / Recruiting
RecruitingNCT07127705
Rapid Response of Stem Cells and Immune Cells for Efficacy
Rapid Response of Stem Cells and Immune Cells for Efficacy: An Acute Randomized Double-blind Placebo-controlled Cross-over Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Natural Immune Systems Inc · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The goal for this clinical trial is to compare rapid effects of four products on stem cells, immune activation, and mitochondrial function. A double-blind, placebo-controlled, cross-over study design will be used.
Detailed description
This clinical trial aims at documenting acute effects of consuming four products through evaluation of stem cell surveillance and mitochondrial resilience. Data on stem cell trafficking will be collected. The testing will show whether consuming the products leads to a rapid change in stem cell surveillance. Data on cellular energy production and mitochondrial resilience in white blood cells under oxidative and inflammatory stress ex vivo will be collected. This testing will show whether consuming the test products leads to support of energy production within mitochondria, under normal and stressed conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Placebo | 2 capsules |
| DIETARY_SUPPLEMENT | Chaga Mushroom | 2 capsules |
| DIETARY_SUPPLEMENT | Ginseng extract | 2 capsules |
| DIETARY_SUPPLEMENT | Olive extract | 2 capsules |
| DIETARY_SUPPLEMENT | Potassium Hydrogen Glucarate | 2 capsules |
Timeline
- Start date
- 2025-05-21
- Primary completion
- 2025-08-27
- Completion
- 2025-10-03
- First posted
- 2025-08-17
- Last updated
- 2025-08-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07127705. Inclusion in this directory is not an endorsement.